Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2015, 28; 442-452; doi: 10.1111/pcmr.12378 | |||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | oligonucleotide | Metafectene | publication | S. Romano et al., Cell Death and Disease, 2013, 4: e578, doi:10.1038/cddis.2013.109 | Link | |||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | plasmid | Metafectene | publication | S. Romano et al., Clinical and Translational Medicine, 2014, 3:1, doi:10.1186/2001-1326-3-1 | Link | |||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Romano et al., Cell Death and Disease, 2013, 4: e578, doi:10.1038/cddis.2013.109 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | |||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Clinical and Translational Medicine, 2014, 3:1, doi:10.1186/2001-1326-3-1 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | plasmid | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2015, 28; 442-452; doi: 10.1111/pcmr.12378 | ||||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | F. Albano et al., Biochimie, 2012, DOI: 10.1016/j.biochi.2012.12.012 | |||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Cell Death and Disease, 2013, 4: e578, doi:10.1038/cddis.2013.109 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
S15VM |
Human primary glioma cells | Human | nervous system | primary cell | plasmid | Metafectene PRO | application note | ![]() |
|||||
RPMI |
Human myeloma B lymphocyte cell line from peripheral blood | Human | immune system | cell line | suspension | plasmid | Metafectene EASY | publication | M. B. Morelli et al., Int. J. Cancer, 2014, 134:2534-2546, DOI:10.1002/ijc.28591 | Link | |||
RPMI |
Human myeloma B lymphocyte cell line from peripheral blood | Human | immune system | cell line | suspension | plasmid | Metafectene EASY | publication | S. Liberati, PhD Thesis, 2014, Sapienza Universita di Roma | Link | |||
RKO |
Human colon carcinoma cell line | ATCC CRL-2577 | Human | digestive organs | cell line | adherent | miRNA | cotransfection (plasmid/miRNA) | Metafectene | publication | S. Guan, Dissertation , 2018, Ruprecht-Karls-Universität Heidelberg | ||
RKO |
Human colon carcinoma cell line | ATCC CRL-2577 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | |
RKO |
Human colon carcinoma cell line | ATCC CRL-2577 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | N. Di Maio et al., FEBS Open Bio, 2017, 7: 1453-1468, doi:10.1002/2211-5463.12307 | Link | |
RKO |
Human colon carcinoma cell line | ATCC CRL-2577 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | K2 Transfection System | publication | Y. Kuslansky et al., Journal of General Virology, 2016, 97: 3313-3330, DOI 10.1099/jgv.0.000624 | Link | |
RKO |
Human colon carcinoma cell line | ATCC CRL-2577 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/miRNA) | Metafectene | publication | S. Guan, Dissertation , 2018, Ruprecht-Karls-Universität Heidelberg | ||
RF24 |
Human umbilical vascular endothelial cells | Human | vasculature | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
RD |
Human rabdomiosarcoma cell line | ATCC CCL-136 | Human | muscle | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
Raji |
Human B lymphocyte cell line | ATCC CCL-86 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | application note | ![]() |
|||
PNT2 |
Human prostate cell line | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
PM-WK |
Human skin malignant melanoma cell line | ATCC CRL-2624 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y |